Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Group X phospholipase A2 is released during sperm acrosome reaction and controls fertility outcome in mice
Jessica Escoffier, … , Gérard Lambeau, Christophe Arnoult
Jessica Escoffier, … , Gérard Lambeau, Christophe Arnoult
Published April 26, 2010
Citation Information: J Clin Invest. 2010;120(5):1415-1428. https://doi.org/10.1172/JCI40494.
View: Text | PDF
Research Article

Group X phospholipase A2 is released during sperm acrosome reaction and controls fertility outcome in mice

  • Text
  • PDF
Abstract

Ejaculated mammalian sperm must undergo a maturation process called capacitation before they are able to fertilize an egg. Several studies have suggested a role for members of the secreted phospholipase A2 (sPLA2) family in capacitation, acrosome reaction (AR), and fertilization, but the molecular nature of these enzymes and their specific roles have remained elusive. Here, we have demonstrated that mouse group X sPLA2 (mGX) is the major enzyme present in the acrosome of spermatozoa and that it is released in an active form during capacitation through spontaneous AR. mGX-deficient male mice produced smaller litters than wild-type male siblings when crossed with mGX-deficient females. Further analysis revealed that spermatozoa from mGX-deficient mice exhibited lower rates of spontaneous AR and that this was associated with decreased in vitro fertilization (IVF) efficiency due to a drop in the fertilization potential of the sperm and an increased rate of aborted embryos. Treatment of sperm with sPLA2 inhibitors and antibodies specific for mGX blocked spontaneous AR of wild-type sperm and reduced IVF success. Addition of lysophosphatidylcholine, a catalytic product of mGX, overcame these deficiencies. Finally, recombinant mGX triggered AR and improved IVF outcome. Taken together, our results highlight a paracrine role for mGX during capacitation in which the enzyme primes sperm for efficient fertilization and boosts premature AR of a likely phospholipid-damaged sperm subpopulation to eliminate suboptimal sperm from the pool available for fertilization.

Authors

Jessica Escoffier, Ikram Jemel, Akemi Tanemoto, Yoshitaka Taketomi, Christine Payre, Christelle Coatrieux, Hiroyasu Sato, Kei Yamamoto, Seiko Masuda, Karin Pernet-Gallay, Virginie Pierre, Shuntaro Hara, Makoto Murakami, Michel De Waard, Gérard Lambeau, Christophe Arnoult

×

Figure 2

Catalytically active mGX sPLA2 is released from sperm during AR.

Options: View larger image (or click on image) Download as PowerPoint
Catalytically active mGX sPLA2 is released from sperm during AR.
   
(A)...
(A) Total amount of mGX protein measured by TRF-IA in supernatants and cell pellets of WT sperm during capacitation (up to 90 minutes) and after AR triggered by addition of the Ca2+ ionophore A23187 (5 μM) between 60 and 90 minutes. “Sum” corresponds to the total amount of mGX in both fractions at various times. (B) Similar assays using mGX–/– sperm, showing no mGX signal (sum of supernatant and pellet [S + P]) before capacitation (0 minutes) and after A23187-induced AR. (C) Total sPLA2 enzymatic activity measured using E. coli radiolabeled enzymatic assays in supernatants and cell pellets of WT sperm during capacitation (n = 5). (D) Similar enzymatic assays using mGX–/– sperm, showing no variation in sPLA2 enzymatic activity throughout capacitation in both fractions (n = 4). (E) sPLA2 enzymatic activities of supernatants and cell pellets of WT sperm (at 90 minutes + A23187) and of recombinant mGX (0.1 nM, n = 2) are inhibited by EDTA (20 mM), DTT (10 mM), LY329722 (10 μM), and anti-mGX antibody (IgG fraction, 5 μg), but not by anti-mGIIA and anti-mGIIF antibodies (n = 2).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts